Health Care: Drugs

Celgene Corporation (CELG: NASDAQ)

$124.91 1.43 | 1.16%
05/17/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:02/27/06
Price Earnings Ratio:37.53
Price Earnings Comparisons:
CELGSector Avg.S&P 500
37.5337.5017.70
Price Performance History (% change):
3 Mo1 Yr3 Yr
25.0276.63107.81
GROWTH12 Mo3 YrCAGR
Revenue13.701.050.27
Net Income10.500.870.23
EPS15.801.000.26
Earnings for CELG:
EBITDA2.20B
REVENUE5.51B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $1.31 $1.29 $5.21 $1,984.89
Number of Analysts 4 4 4 5
High Estimate $1.36 $1.37 $5.46 $9,899.00
Low Estimate $1.25 $1.26 $5.08 $5.91
Prior Year $1.12 $1.19 $4.50 $5.21
Growth Rate (Year over Year) 16.74% 8.61% 15.78% 37,997.70%

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter